Article Text

other Versions

PDF
Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis. Association between elevated endothelin plasma levels and the development of ischemic events.
  1. Ester Lozano (elozano{at}clinic.ub.es)
  1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
    1. Marta Segarra (segarram{at}mail.nih.gov)
    1. Center for Cancer Research, National Cancer Institute (NCI), NIH, Bethesda, United States
      1. Marc Corbera-Bellalta (mcorbera{at}clinic.ub.es)
      1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
        1. Ana García-Martínez (angarcia{at}clinic.ub.es)
        1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
          1. Georgina Espígol-Frigolé (gespigol{at}clinic.ub.es)
          1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
            1. Ana Plà-Campo (esterlozan{at}yahoo.es)
            1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
              1. José Hernández-Rodríguez (jhernan{at}clinic.ub.es)
              1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain
                1. Maria C Cid (mccid{at}clinic.ub.es)
                1. Dept of Systemic Autoimmune Diseases. Hospital Clínic. University of Barcelona, IDIBAPS, Barcelona, Spain

                  Abstract

                  Objective: About 15- 20 % of patients with giant-cell arteritis (GCA) develop ischemic complications often preceded by transient ischemia. We investigated the expression of the endothelin (ET) system in GCA lesions, to assess its relationship with the development of ischemic complications.

                  Methods: Plasma ET-1 was quantified by immunoassay in 61 patients with biopsy-proven GCA and 16 healthy donors. ET-1, endothelin converting enzyme (ECE-1) and ET receptor (ETAR and ETBR) mRNAs were measured by real-time quantitative RT-PCR in temporal arteries from 35 of these patients and 19 control arteries. Proteins were measured by immunoassay and western-blot.

                  Results: ET-1 concentration was increased at the protein level in temporal artery samples from GCA patients compared to controls (0.28±0.098 [x±SEM] vs 0.98±0.32 fmol/mg, p=0.028). ECE-1, ETAR and ETBR /actin ratios (western-blot) were also significantly higher in GCA patients. Intriguingly, mRNA expression of ET-1, ECE-1 and both receptors was significantly reduced in GCA lesions compared to control arteries. When investigating mechanisms underlying these results, we found that PDGF and IL-1β, present in GCA lesions, down-regulated ET-1 mRNA in cultured human temporal artery-derived smooth muscle cells. Glucocorticoid treatment for 8 days did not result in significantly decreased ET tissue concentration (0.87±0.2 vs 0.52±0.08;p=0.6). Plasma ET concentrations were higher in patients with ischemic complications (1.049±0.48 vs 1.205±0.63 pg/mL,p= 0.032).

                  Conclusions: The ET system is increased at the protein level in GCA lesions creating a microenvironment prone to the development of ischemic complications. Recovery induced by glucocorticoids is delayed, indicating persistent exposure to ET during initial treatment.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.